JOHANNESSEN JAN 4
4 · Twist Bioscience Corp · Filed Nov 19, 2021
Insider Transaction Report
Form 4
JOHANNESSEN JAN
Director
Transactions
- Exercise/Conversion
Common Stock
2021-11-17$14.00/sh+5,000$70,000→ 6,898 total - Sale
Common Stock
2021-11-17$115.17/sh−5,000$575,850→ 1,898 total - Exercise/Conversion
Director Stock Option (right to buy)
2021-11-17−5,000→ 27,304 totalExercise: $14.00Exp: 2028-10-29→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.
- [F2]1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.